Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Mar 5, 2009

Premium

Eksigent last week introduced the cHIPLC-nanoflex system for proteomics research.

The system is a docking station for up to three microfluidic chips that contain nanoLC or trap columns. The company's proprietary EksPort microconnector system ensures "reliable and consistent fluidic connections to facilitate column changes," it said in a statement

The system can be added to any of Eksigent's nanoLC systems or Applied Biosystems' Tempo nano LC systems.


ForteBio this week launched the Anti-Human IgG Fc Capture biosensor for the kinetic characterization and screening of human IgG antibodies and other Fc-containing proteins.

The biosensor is for use on the company's Octet instrument platform and leverages its proprietary Bio-Layer interferometry technology "to enable kinetic profiling of human IgGs against analyte in a microplate well format," ForteBio said in a statement. The sensor can also be used to conduct ligand-inhibition assays, it added.


AnaSpec last week added Exendin peptides to its Go Peptide line of on-demand peptides.

The new products include fluorescein-Trp25-Exendin-4 and [Cys(hiLyteFluor 647 C2 maleimide)]-Exendin-4, two peptides "that are not immediately available anywhere else," the company said in a statement.


Premier Biosoft this week launched version 2.7 of SimGlycan, an MS/MS data analysis tool with the ability to draw glycans and annotate spectra with cartoons.

Users can now draw glycans and glycopeptides, fragment them, and search the database "to see how close the structure is to the MS/MS experimental data loaded," the company said in a statement. Mass spectra can be annotated with cartoons or Domon-Costello-based nomenclature, Premier added.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.